AMEC to design of global vaccine research centre for Shire Pharmaceuticals

Published: 15-Apr-2003


International engineering services company AMEC has been awarded a major contract to provide detailed design and construction services for a new US$18.5m (€17.2m) global vaccine research centre for UK-based Shire Pharmaceuticals Group. The Centre will support Shire's biologics business and will be located at the company's current site in Laval, Quebec, alongside Shire's therapeutic research centre.

AMEC's global PharmaChem unit will provide detailed design and construction services for a mix of renovation and extension of the facility. The centre will provide approximately 70,000ft2 of laboratory and office space and will host scientists from both therapeutic and biologic research. Work on the project is expected to be completed during the first half of 2004.

AMEC's vaccine research centre project team consists of specialist design groups from AMEC's offices fin Oakville, Ontario; Montreal, Quebec; Lawrenceville, New Jersey; and Stratford-upon-Avon, UK. Last year, AMEC was awarded a contract to provide full design, management and construction services for Shire's new corporate head office in Basingstoke, UK.

You may also like